0.06
4.15%
-0.0026
시장 영업 전:
.06
Eyenovia Inc 주식(EYEN)의 최신 뉴스
Financial Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) & Eyenovia (NASDAQ:EYEN) - Defense World
Eyenovia secures $1 million from warrant repricing and exercise - MSN
Eyenovia secures $1 million from warrant repricing and exercise By Investing.com - Investing.com Canada
SEC Form 424B3 filed by Eyenovia Inc. - Quantisnow
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote 'FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - The Manila Times
Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewswire Inc.
Ladenburg Thalmann Downgrades Eyenovia (EYEN) - MSN
Geode Capital Management LLC Increases Stock Position in Eyenovia, Inc. (NASDAQ:EYEN) - Defense World
Deal Dispatch: TD Bank To Sell Charles Schwab Stake? Eyenovia, Smart Share Hit Auction Block - Benzinga
Mydriasis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight - The Globe and Mail
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc - The Globe and Mail
Eyenovia Eyes Cost-Cutting Measures Amid Disappointing Study Results - MPO-mag
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA - openPR
Eyenovia explores strategic alternatives, advances Optejet device By Investing.com - Investing.com Nigeria
Eyenovia Hires Financial Adviser Amid Business Review - MarketWatch
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewswire
Eyenovia explores strategic alternatives, advances Optejet device - Investing.com
Eyenovia Explores Strategic Alternatives, Accelerates Optejet Device Development Plans - StockTitan
Eyenovia (NASDAQ:EYEN) Enters into Amended and Restated Sales Agreement with Chardan Capital Markets, LLC - Defense World
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
SEC Form 424B5 filed by Eyenovia Inc. - Quantisnow
Eyenovia faces Nasdaq delisting over low stock price By Investing.com - Investing.com Nigeria
Eyenovia faces Nasdaq delisting over low stock price - Investing.com
Eyenovia (NASDAQ:EYEN) Announces Completion of Registered Direct Offering - Defense World
Eyenovia’s $1.9M Offering to Boost Optejet Development - TipRanks
Form 424B5 EYENOVIA, INC. - StreetInsider.com
Eyenovia announces pricing of $1.9M registered direct offering - MSN
Eyenovia secures $1.9 million in direct offering By Investing.com - Investing.com Canada
Eyenovia secures $1.9 million in direct offering - Investing.com
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewswire
Eyenovia Announces $1.9M Direct Offering to Fund Optejet Development, Strategic Growth - StockTitan
These Numbers Show Just How Powerful Eyenovia Inc (NASDAQ: EYEN) Stock Is - Stocks Register
Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Update - Defense World
Eyenovia’s Direct Offering to Support Strategic Initiatives - TipRanks
Eyenovia secures $1.3 million in direct offering By Investing.com - Investing.com South Africa
Eyenovia defers loan payments, issues equity to lenders - Investing.com
Eyenovia defers loan payments, issues equity to lenders By Investing.com - Investing.com Canada
Eyenovia Slumps On Pricing Of Registered Direct Offering - Nasdaq
Eyenovia Restructures Finances and Leadership Team - TipRanks
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering - The Manila Times
Eyenovia secures $1.3 million in direct offering - Investing.com
Eyenovia Raises $1.3M in Direct Offering at $0.1076 Per Share with Warrants | EYEN Stock News - StockTitan
자본화:
|
볼륨(24시간):